GISTs are solid tumors, primarily in the stomach, characterized by KIT and EGFR mutations, with Gleevec as a key treatment.
KIT-exon-11 mutations in GISTs correlate with higher partial response rates and improved surgical outcomes with neoadjuvant Gleevec. Non-KIT exon 11 mutations and wild-type KIT/PDGFRA GISTs show less ...
"I feel really good ... I see the world differently," newlywed Ariana Pulido said of life post-surgery Becca Longmire is a digital news writer-reporter at PEOPLE. She has been working at PEOPLE since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback